|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.585
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.477
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.469
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.451
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.416
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.391
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.371
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.359
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.341
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.332
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.326
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.283
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.269
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.263
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.262
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.232
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.232
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.224
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.224
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.221
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.220
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.219
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.219
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.217
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.213
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.213
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.212
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.205
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.185
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.180
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.178
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.176
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.174
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.174
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.168
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.167
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.163
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.160
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.159
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.158
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.151
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.148
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.148
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.148
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.144
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.142
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.140
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.140
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.137
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.137
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.133
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.131
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.129
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.125
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.125
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.124
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.122
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.121
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.119
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.119
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.117
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.116
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.115
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.114
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.112
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.108
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.106
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.103
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.102
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.101
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.101
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.099
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.098
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.098
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.098
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.097
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.097
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.096
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.095
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.095
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.095
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.095
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.092
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.092
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.091
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.090
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.090
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.090
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.089
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.087
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.087
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.084
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.084
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.084
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.083
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.081
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.081
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.081
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.081
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.080
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.078
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.078
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.078
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.077
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.076
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.076
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.074
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.074
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.073
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.072
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.071
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.070
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.070
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.069
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.068
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.068
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.068
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.068
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.067
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.066
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.066
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.066
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.066
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.066
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.066
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.066
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.065
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.064
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.063
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.063
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.063
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.063
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.063
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.063
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.062
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.062
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.062
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.062
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.061
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.061
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.060
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.060
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.059
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.059
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.059
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.059
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.058
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.058
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.058
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.058
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.056
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.056
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.056
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.055
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.055
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.054
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.054
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.054
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.053
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.053
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.053
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.053
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.052
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.051
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.051
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.051
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.051
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.051
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.050
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.050
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.050
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.049
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.048
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.047
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.047
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.047
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.047
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.047
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.047
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.047
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.046
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.046
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.046
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.046
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.046
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.046
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.045
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.044
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.044
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.044
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.044
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.044
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.044
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.044
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.043
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.043
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.043
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.043
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.043
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.043
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.042
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.042
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.042
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.042
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.042
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.042
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.042
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.042
|
|
|
|
connective tissue replacement involved in inflammatory response wound healing
|
GO:0002248 |
3 |
0.041
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.041
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.041
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.041
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.041
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.041
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.041
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.040
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.040
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.040
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.040
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.040
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.040
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.040
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.039
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.039
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.039
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.039
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.039
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.039
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.039
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.038
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.038
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.038
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.038
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.038
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.038
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.037
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.037
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.037
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.036
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.036
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.036
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.036
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.036
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.036
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.035
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.035
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.035
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.035
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.035
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.035
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.035
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.035
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.035
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.035
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.035
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.035
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.035
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.035
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.035
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.035
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.034
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.034
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.034
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.034
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.034
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.034
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.033
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.033
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.033
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.033
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.033
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.033
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.033
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.033
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.033
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.033
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.033
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.033
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.032
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.032
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.032
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.032
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.032
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.032
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.032
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.032
|
|
|
|
protein homotrimerization
|
GO:0070207 |
4 |
0.032
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.032
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.032
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.031
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.031
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.031
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.031
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.031
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.031
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.031
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.031
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.031
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.031
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.031
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.031
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.031
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.030
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.030
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.030
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.030
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.030
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.030
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.030
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.030
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.030
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.030
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.029
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.029
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.029
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.029
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.029
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.029
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.029
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.029
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.029
|
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.029
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.029
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.029
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.029
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.029
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.029
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.029
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.029
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.029
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.029
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.029
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.028
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.028
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.028
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.028
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.028
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.028
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.028
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.028
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.028
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.028
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.027
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.027
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.027
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.027
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.027
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.027
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.027
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.027
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.027
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.027
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.027
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.027
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.027
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.027
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.027
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.027
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.027
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.026
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.026
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.026
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.026
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.026
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.026
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.026
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.026
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.026
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.026
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.026
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.026
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.026
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.025
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.025
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.025
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.025
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.025
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.025
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.025
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.025
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.025
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.025
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.025
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.024
|
|
|
|
oxidative demethylation
|
GO:0070989 |
1 |
0.024
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.024
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.024
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.024
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.024
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.024
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.024
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.024
|
|
|
|
alpha amino acid biosynthetic process
|
GO:1901607 |
15 |
0.024
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.024
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.024
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.024
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.024
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.024
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.024
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.024
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.024
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.024
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.024
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.024
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.024
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.024
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.024
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.023
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.023
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.023
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.023
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.023
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.023
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.023
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.023
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.023
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.023
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.023
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.023
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.023
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.023
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.023
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.022
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.022
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.022
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.022
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.022
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.022
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.022
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.022
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.022
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.022
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.021
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.021
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.021
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.021
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.021
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.021
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.021
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.021
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.021
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.021
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.021
|
|
|
|
negative regulation of cell adhesion mediated by integrin
|
GO:0033629 |
2 |
0.021
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.021
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.021
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.021
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.021
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.021
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.021
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.021
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.021
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.021
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.021
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.021
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.021
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.021
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.021
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.021
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.021
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.021
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.021
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.021
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.020
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.020
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.020
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.020
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.020
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.020
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.020
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.020
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.020
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.020
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.020
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.020
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.020
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.020
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.020
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.020
|
|
|
|
regulation of membrane depolarization during cardiac muscle cell action potential
|
GO:1900825 |
1 |
0.020
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.020
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.020
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.020
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.019
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.019
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.019
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.019
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.019
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.019
|
|
